MBX - Mbx Biosciences, Inc.

Insider activity in MBX over the last quarter tilts toward selling: insiders offloaded a net 370 shares worth roughly $24K.

Classified under Biotechnology (Health Care sector), MBX's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Hawryluk P. Kent	727.7K	$21.50M	-
CEO	Hoerter Steven L.	82.9K	-	-
CFO	Smither John W	28.0K	-	-
CFO	Bartram Richard	15.0K	-	-
Other	Azoulay Salomon	14.4K	$947.0K	-

Buys and sells only

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 4, 2026	Azoulay Salomon	Chief Medical Officer	Sell	370	$65.77	$24,334.90	-2.5%	-	-
May 8, 2026	Azoulay Salomon	Chief Medical Officer	Sale+OE10b5-1	70,003	$38.36	$2,685,514.90	-82.6%	+63.8%	-
May 6, 2026	Hawryluk P. Kent80	President &CEO	Sell	607	$29.54	$17,930.78	-	+120.1%	-
May 6, 2026	Azoulay Salomon	Chief Medical Officer	Sell	231	$29.54	$6,823.74	-1.5%	+120.1%	-
Mar 13, 2026	Hawryluk P. Kent80	President &CEO	Buy	18,500	$28.41	$525,662.70	+4.0%	+33.0%	-
Oct 20, 2025	Hawryluk P. Kent80	President &CEO	Buy	20,000	$13.64	$272,790.00	+4.5%	+203.2%	+276.0%
Oct 17, 2025	Hoerter Steven L.	Director	Buy	20,000	$13.25	$264,984.00	New	+209.5%	+275.3%
Sep 26, 2025	Heron Patrick J87	Director, 10% Owner	Buy	666,666	$18.00	$11,999,988.00	+14.6%	+76.5%	+206.3%
Apr 8, 2025	Pescovitz Ora H.	Director	Buy	7,693	$5.89	$45,311.77	+46.2%	+122.5%	+446.8%
Feb 18, 2025	Gordon Carl L74	Director, 10% Owner	Buy	190,672	$10.60	$2,020,755.60	+34.2%	+11.5%	+269.8%